These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20826436)

  • 21. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
    Pronk JC; Leegwater PA; van der Knaap MS
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
    Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
    Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocytic hypertrophy in dysmyelination influences the diffusion anisotropy of white matter.
    Harsan LA; Poulet P; Guignard B; Parizel N; Skoff RP; Ghandour MS
    J Neurosci Res; 2007 Apr; 85(5):935-44. PubMed ID: 17278151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
    Bugiani M; Postma N; Polder E; Dieleman N; Scheffer PG; Sim FJ; van der Knaap MS; Boor I
    Brain; 2013 Jan; 136(Pt 1):209-22. PubMed ID: 23365098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominant form of vanishing white matter-like leukoencephalopathy.
    Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
    Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
    Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
    J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT; Wu C; Fecenko-Tacka K
    J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
    Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R
    Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukoencephalopathy with vanishing white matter: a review.
    Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
    Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M
    J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demyelination of the hippocampus is prominent in the cuprizone model.
    Koutsoudaki PN; Skripuletz T; Gudi V; Moharregh-Khiabani D; Hildebrandt H; Trebst C; Stangel M
    Neurosci Lett; 2009 Feb; 451(1):83-8. PubMed ID: 19084049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.
    Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O
    J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
    Lindner M; Heine S; Haastert K; Garde N; Fokuhl J; Linsmeier F; Grothe C; Baumgärtner W; Stangel M
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):105-14. PubMed ID: 17961136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine leukodystrophies as tools to study myelinogenesis in normal and pathological conditions.
    Matthieu JM; Omlin FX
    Neuropediatrics; 1984 Sep; 15 Suppl():37-52. PubMed ID: 6085935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
    Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
    Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal demyelination in Alzheimer's disease and transgenic mouse models.
    Mitew S; Kirkcaldie MT; Halliday GM; Shepherd CE; Vickers JC; Dickson TC
    Acta Neuropathol; 2010 May; 119(5):567-77. PubMed ID: 20198482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association.
    Sanahuja J; Franco E; Rojas-García R; Gallardo E; Combarros O; Begué R; Granés P; Illa I
    Arch Neurol; 2005 Dec; 62(12):1911-4. PubMed ID: 16344349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.